https://hipa.ai/drug/tofacitinib/updates/boxed-warning-revised-tofacitinib-label-effective-2026-07-27-2026-07-27 Hipa.ai en 2026-07-27T00:00:00.000Z Tofacitinib Boxed Warning Revised to Include Mortality, MACE, and Thrombosis https://hipa.ai/drug/liraglutide/updates/boxed-warning-revised-liraglutide-label-effective-2026-07-27-2026-07-27 Hipa.ai en 2026-07-27T00:00:00.000Z Liraglutide Boxed Warning Revised for Thyroid C-Cell Tumor Risk https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05714553-2026-07-23 Hipa.ai en 2026-07-23T00:00:00.000Z Pembrolizumab Combination Shows Objective Response in Advanced Solid Tumors https://hipa.ai/drug/guselkumab/updates/trial-results-posted-nct05071664-2026-07-23 Hipa.ai en 2026-07-23T00:00:00.000Z Guselkumab Plus Golimumab Improves Psoriatic Arthritis ACR 50 Response https://hipa.ai/drug/tofacitinib/updates/boxed-warning-present-label-tofacitinib-label-effective-2026-2026-07-23 Hipa.ai en 2026-07-23T00:00:00.000Z Tofacitinib Label Revised for Mortality, MACE, Thrombosis Boxed Warning